NCT03258554 2026-02-06Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take CisplatinNational Cancer Institute (NCI)Phase 2/3 Completed196 enrolled 31 charts